Here Are 3 Hot Things to Know About Stocks Right Now
- The Dow Jones Industrial Average was higher Monday amid improved prospects for a trade agreement between the U.S. and China.
- General Electric Co. (GE) rose 6.1% Monday following a report that suggested Apollo Global Management LLC (APO) could be preparing a $40 billion bid for the company's airplane leasing division.
- Eli Lilly & Co. (LLY) reached an agreement to buy biopharmaceutical company Loxo Oncology Inc. (LOXO) for $235 a share in cash, or about $8 billion.
Wall Street Overview
Stocks rose on Monday, Jan. 7, following Friday's rally that was fueled by much stronger-than-expected U.S. jobs data and dovish messages from the Federal Reserve.
Giving equities a lift Monday were improved prospects for a trade agreement between the U.S. and China.
The Dow Jones Industrial Average rose 98 points, or 0.42%, to 23,531, the S&P 500 rose 0.7%, and the Nasdaq was up 1.26%.
Stocks surged on Friday after the U.S. added 312,000 jobs to payrolls in December, smashing economists' estimates, and after Fed Chairman Jerome Powell said the central bank would be "patient" when it comes to raising interest rates as it monitors incoming data.
"As always, there is no preset path for policy," Powell said Friday during a panel discussion in Atlanta. "And particularly with muted inflation readings that we've seen coming in, we will be waiting as we watch to see how the economy evolves."
Powell also said he wouldn't resign if asked to by Donald Trump, who has criticized the central bank for raising U.S. interest rates too quickly.
The prospects for a trade deal between the U.S. and China were buoyed by comments from Donald Trump, who told reporters Sunday that the world's second-largest economy is "not doing well ... I think that gives them a great incentive to negotiate." U.S. officials had their first face-to-face meeting of the year Monday in Beijing as part of a two-day round of talks aimed at advancing the framework set out by Trump and China's President Xi Jinping last month in Argentina.
Trump and Xi reached an agreement Dec. 1 to postpone further increases in tariffs.
General Electric Co. (GE) shares were up 6.1% Monday following a report that suggested Apollo Global Management LLC (APO) could be preparing a $40 billion bid for the company's airplane leasing division.
Bloomberg reported that the private-equity group was in the process of securing around $30 billion in funding for a bid to buy all or part of GE Capital Aviation Services, a wholly owed unit of GE with a near 2,000-strong fleet of aircraft that generated around $271 million in third-quarter profit. Reuters reported similar interest in the aviation unit on Friday as well, with both news organizations citing an enterprise value of $40 billion.
A sale would raise considerable capital for cash-strapped GE and accelerate the dismantling of GE Capital, the company's financing arm, Bloomberg noted. GE also is taking steps to spin off its healthcare unit, Bloomberg has reported, to narrow its focus on building jet engines and power equipment.
Eli Lilly & Co. (LLY) reached an agreement to buy biopharmaceutical company Loxo Oncology Inc. (LOXO) for $235 a share in cash, or about $8 billion, in the second major pharmaceutical sector deal of the year.
The price represents a 68% premium to Loxo Oncology's closing price of $139.87 on Friday. The transaction isn't subject to any financing condition and is expected to close by the end of the first quarter of 2019, the companies said. The takeover comes just days after Bristol-Myers Squibb Co. (BMY) agreed to buy Celgene Corp. (CELG) in a deal that values the company at $74 billion.
"We are excited to have reached this agreement with a team that shares our commitment to ensuring that emerging translational science reaches patients in need," said Jacob Van Naarden, chief operating officer of Loxo Oncology. "We are confident that the work we have started, which includes an FDA approved drug, and a pipeline spanning from Phase 2 to discovery, will continue to thrive in Lilly's hands."
Eli Lilly shares rose 0.6%, while Loxo Oncology shares jumped 66% to $232.65. Other stocks in the sector also were rising -- Clovis Oncology Inc. (CLVS) was up 18.5%, and Epizyme Inc. (EPZM) rose 5.8%.
Amazon.com Inc. (AMZN) was up 3.4% to $1,629.51 after analysts an Pivotal Research initiated coverage on the stock with a price target that suggests more than 20% upside potential for the world's biggest online retailer.
Pivotal analyst Brian Wieser pegged a year-end price target of $1,920 a share for Amazon as he initiated coverage of the stock with a "buy" recommendation based on the company's retail activities as a play on global consumer spending, which some estimate at nearly $45 trillion. Pivotal also sees Amazon's advertising business, which generated around $9 billion in revenue last year, as having the ability to provide "incremental growth" that's independent of consumer spending.
"Amazon is one of the world's largest retailers (with a sideline in fast-growing and high-margin advertising activities) and also owns one of the world's largest software businesses," Wieser wrote. "Despite its current massive size, we see Amazon's opportunities as mostly unconstrained based on a successful track record of capitalizing on consumer and IT department spending."
Tesla Inc. (TSLA) broke ground for a factory in China and will start production of its Model 3 and a planned crossover - the Model Y - by the end of the year, CEO Elon Musk said Monday.
Looking forward to breaking ground on the @Tesla Shanghai Gigafactory today!— Elon Musk (@elonmusk) January 7, 2019
Musk also said in later tweets that Tesla was "Aiming to finish initial construction this summer, start Model 3 production end of year & reach high volume production next year."
Tesla was up 5.44%.